BioScience Health Innovations I (BHIC)
OTC Markets OTCID
Price as at 30 Sept 2026, 16:30 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
BioScience Health Innovations I trades at $7.99. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About BioScience Health Innovations I
BioScience Health Innovations, Inc. operates as a health and wellness innovation company focuses on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States. It offers nutritional supplements, peptides, and bioactive compounds through its core technology Mineral Oxide Delivery System, as well as provides Oracle NetSuite, an accounting and financial reporting system. The company also provides services, including testosterone and hormonal Optimization, NAD+ and cellular health, and platform licensing and peptide delivery. It sells its products through Amazon platform; and direct-to-consumer. The company was formerly known as Nowtransit Inc and changed its name to BioScience Health Innovations, Inc. in February 2025. BioScience Health Innovations, Inc. is based in Bluffdale, Utah.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Common questions
Where does SteadyShares get its BHIC data?
Fundamentals for BHIC come from company filings and exchange data, as listed on OTC Markets OTCID; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 16:30 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for BHIC, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.